ロード中...
Current targeted therapeutics against COVID-19: Based on first-line experience in China
SARS-CoV-2 is a novel strain, causing a global pandemic since the end of 2019. The majority of patients showed nonspecific symptoms such as fever, dry cough, and fatigue. Most patients have a good prognosis while some with severe conditions could rapidly progress to acute respiratory distress syndro...
保存先:
| 出版年: | Pharmacol Res |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier Ltd.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7192075/ https://ncbi.nlm.nih.gov/pubmed/32360585 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.phrs.2020.104854 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|